Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843246 | PMC |
| http://dx.doi.org/10.1053/j.gastro.2021.01.216 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Enhanced recovery following neck of femur fractures - improving outcomes : a survey of current perioperative practice.
Bone Jt Open
September 2025
School of Medicine, University of Nottingham, Nottingham, UK.
Aims: The number of hip fractures is increasing, with significant mortality and morbidity, particularly among frail and comorbid patients. Enhanced recovery after surgery (ERAS) pathways have proven effective in elective orthopaedics, but this has not been investigated in people with hip fractures. This study aimed to identify current perioperative practice and develop a cohesive ERAS pathway tailored for hip fracture patients, to standardize and optimize care.
View Article and Find Full Text PDFRugged LC-MS/MS method for the large-scale monitoring of glyphosate and other highly polar pesticides in soils across European Union olive orchards.
Environ Pollut
September 2025
Universidad de Jaén, Analytical Chemistry Research Group (FQM 323), Departamento de Química Física y Analítica, Campus Las Lagunillas Edif. B3, 23071 Jaén, Spain; University Research Institute for Olives Grove and Olive Oil (INUO), Universidad de Jaén, Jaén, Spain.
Glyphosate (GLY) is the most widely used herbicide globally. Despite concerns regarding its potential adverse effects on human health and the environment, its use continues to grow each year. Following application, a substantial proportion of glyphosate infiltrates the soil, where it can degrade into transformation products such as aminomethylphosphonic acid (AMPA), which is much more persistent than the parent compound.
View Article and Find Full Text PDFGeneralizability of SURPASS-CVOT to the United States: A Nationally Representative Study.
Prog Cardiovasc Dis
September 2025
Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address:
Pathogenic Cardiomyopathy-Associated Gene Variants and Prognosis in Atrial Fibrillation: Results in 18,000 Clinical Trial Participants.
J Am Coll Cardiol
September 2025
Thrombolysis in Myocardial Infarction Study Group, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. Electronic address:
Background: Genetic variants in cardiomyopathy genes are associated with risk of atrial fibrillation (AF), although data on clinical outcomes for AF patients with such variants remain sparse.
Objectives: We aimed to study the prognostic implication of rare cardiomyopathy-associated pathogenic variants (CMP-PLP) in AF patients from large, well-phenotyped clinical trials.
Methods: CMP-PLP carriers were identified using exome sequencing in 5 multinational trials from the Thrombolysis in Myocardial Infarction study group (ENGAGE AF, FOURIER, SAVOR, PEGASUS, and DECLARE), with replication in the EAST-AFNET-4 trial.
The predictive validity of pontine volume change in spinocerebellar ataxia type 1 (SCA1).
Neurobiol Dis
September 2025
Department of Neurology, Donders Institute for Brain, Cognition, and Behavior, Radboud University Medical Center, the Netherlands. Electronic address:
Background: Pontine volume previously emerged as a sensitive MR marker to track disease progression in SCA1. To accept this marker as a surrogate clinical trial endpoint, long-term follow-up is necessary to confirm its sensitivity to change and to establish its predictive validity.
Objective: (1)Confirm the sensitivity to change in pontine volume after two years and identify predictors of volume reduction, and (2)to evaluate the predictive value of one-year changes in pontine volume on subsequent clinical progression after two years.